Effectiveness of focused ultrasound for high risk human papillomavirus infection-related cervical lesions

References

• Bhatla N, Aoki D, Sharma DN, et al. Cancer of the cervix uteri. Int J Gynaecol Obstet. 2018;143(Suppl 2):22–36.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China. CA Cancer J Clin. 2016;66(2):115–132.,
   PubMed Web of Science ®Google Scholar
• Ostör AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol. 1993;12(2):186–192.
   PubMed Web of Science ®Google Scholar
• Liu M, Yan X, Zhang M, et al. Influence of human papillomavirus infection on the natural history of cervical intraepithelial neoplasia 1: a meta-analysis. Biomed Res Int. 2017;2017:8971059.
   PubMed Web of Science ®Google Scholar
• Waller J, McCaffery K, Kitchener H, et al. Women's experiences of repeated HPV testing in the context of cervical cancer screening: a qualitative study. Psychooncology. 2007;16(3):196–204.
   PubMed Web of Science ®Google Scholar
• Henk HJ, Insinga RP, Singhal PK, et al. Incidence and costs of cervical intraepithelial neoplasia in a us commercially insured population. J Low Genit Tract Dis. 2010;14(1):29–36.,
   PubMed Web of Science ®Google Scholar
• Kola-Palmer S, Walsh JC. Correlates of psychological distress immediately following colposcopy. Psychooncology. 2015;24(7):819–824.
   PubMed Web of Science ®Google Scholar
• Mizukami A, Kaise T, Van Kriekinge G. Resource use and cost of treating human papillomavirus-related lesions in japanese women. Value Health Reg Issues. 2018;15:56–62.
   PubMedGoogle Scholar
• Kyrgiou M, Athanasiou A, Paraskevaidi M, et al. Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis. BMJ. 2016;354:i3633.,
   PubMed Web of Science ®Google Scholar
• Xiong Y, Cui L, Bian C, et al. Clearance of human papillomavirus infection in patients with cervical intraepithelial neoplasia: A systemic review and meta-analysis. Medicine (Baltimore). 2020;99(46):e23155.
   PubMed Web of Science ®Google Scholar
• Terenzi F, Saikia P, Sen GC. Interferon-inducible protein, P56, inhibits HPV DNA replication by binding to the viral protein E1. Embo J. 2008;27(24):3311–3321.
   PubMed Web of Science ®Google Scholar
• Eron LJ, Judson F, Tucker S, et al. Interferon therapy for condylomata acuminata. N Engl J Med. 1986;315(17):1059–1064.
   PubMed Web of Science ®Google Scholar
• Rockley PF, Tyring SK. Interferons alpha, beta and gamma therapy of anogenital human papillomavirus infections. Pharmacol Ther. 1995;65(2):265–287.
   PubMed Web of Science ®Google Scholar
• Koromilas AE, Li S, Matlashewski G. Control of interferon signaling in human papillomavirus infection. Cytokine Growth Factor Rev. 2001;12(2-3):157–170.
   PubMed Web of Science ®Google Scholar
• Shi HJ, Song HB, Zhao QY, et al. Efficacy and safety of combined high-dose interferon and red light therapy for the treatment of human papillomavirus and associated vaginitis and cervicitis: A prospective and randomized clinical study. Medicine. 2018;97(37):e12398
   PubMed Web of Science ®Google Scholar
• van den Bijgaart RJ, Eikelenboom DC, Hoogenboom M, et al. Thermal and mechanical high-intensity focused ultrasound: perspectives on tumor ablation, immune effects and combination strategies. Cancer Immunol Immunother. 2017;66(2):247–258.,
   PubMed Web of Science ®Google Scholar
• Chen J, Zhou D, Liu Y, et al. A comparison between ultrasound therapy and laser therapy for symptomatic cervical ectopy. Ultrasound Med Biol. 2008;34(11):1770–1774.,
   PubMed Web of Science ®Google Scholar
• Li CZ, Wang ZB, Yang X, et al. Feasibility of focused ultrasound therapy for recurrent cervicitis with high-risk human papillomavirus infection. Ultrasound Obstet Gynecol. 2009;34(5):590–594.,
   PubMed Web of Science ®Google Scholar
• Fu Z, Fan Y, Wu C, et al. Clinical efficacy and mechanism for focused ultrasound (FUS) in the management of cervical intraepithelial neoplasia 1 (CIN1). Int J Hyperthermia. 2020;37(1):339–345.
   PubMed Web of Science ®Google Scholar
• Li C, Xiong X, Li Y, et al. Therapeutic effects of focused ultrasound in 4014 patients with symptomatic cervical ectopy. Ultrasound Med Biol. 2013;39(4):604–610.,
   PubMed Web of Science ®Google Scholar
• Perkins RB, Guido RS, Castle PE, et al.; A.R.-B.M.C.G. Committee. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2020;24(2):102–131.
   PubMed Web of Science ®Google Scholar
• Mark S, Kinney WK, *, Cheung LC, et al. Relative performance of HPV and cytology components of cotesting in cervical screening. JNCI J Natl Cancer Inst. 2018;110:1–8.
   Web of Science ®Google Scholar
• Diane Solomon M, Diane Davey M, Robert Kurman M, et al.; Bethesda 2001 Workshop. The 2001 bethesda system: terminology for reporting results of cervical cytology. JAMA. 2002;287(16):2114–2119.
   PubMed Web of Science ®Google Scholar
• Wang Y, Xue J, Dai X, et al. Distribution and role of high-risk human papillomavirus genotypes in women with cervical intraepithelial neoplasia: a retrospective analysis from Wenzhou, southeast China. Cancer Med. 2018;7(7):3492–3499.
   PubMed Web of Science ®Google Scholar
• Pinder LF, Parham GP, Basu P, et al. Thermal ablation versus cryotherapy or loop excision to treat women positive for cervical precancer on visual inspection with acetic acid test: pilot phase of a randomised controlled trial. Lancet Oncol. 2020;21(1):175–184.
   PubMed Web of Science ®Google Scholar
• Aerssens A, Claeys P, Garcia A, et al. Natural history and clearance of HPV after treatment of precancerous cervical lesions. Histopathology. 2008;52(3):381–386.
   PubMed Web of Science ®Google Scholar
• Stanley M, Chapter 1. Genital human papillomavirus infections–current and prospective therapies. J Natl Cancer Inst Monogr. 2003;2003(31):117–124.
   Google Scholar
• Hampson L, Martin-Hirsch P, Hampson IN. An overview of early investigational drugs for the treatment of human papilloma virus infection and associated dysplasia. Expert Opin Investig Drugs. 2015;24(12):1529–1537.
   PubMed Web of Science ®Google Scholar
• Zhang W, Gong X, Wu Q, et al. The clearance of high-risk human papillomavirus is sooner after thin loop electrosurgical excision procedure (t-LEEP). J Invest Surg. 2019;32(6):560–565.
   PubMed Web of Science ®Google Scholar
• Zhao XL, Hu SY, Zhang Q, et al. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population. J Gynecol Oncol. 2017;28(4):e30.
   PubMed Web of Science ®Google Scholar
• Mai Q, Yang X, Cheng H, et al. Prevalence and genotype distribution of human papillomavirus among women with cervical lesions in Shenzhen city, China. Hum Vaccin Immunother. 2020;17(4):965–971.
   PubMed Web of Science ®Google Scholar
• Ma L, Lei J, Ma L, et al. Characteristics of women infected with human papillomavirus in a tertiary hospital in Beijing China, 2014-2018. BMC Infect Dis. 2019;19(1):670.,
   PubMed Web of Science ®Google Scholar
• Li K, Yin R, Li Q, et al. Analysis of HPV distribution in patients with cervical precancerous lesions in Western China. Medicine. 2017;96(29):e7304
   PubMed Web of Science ®Google Scholar
• Oyervides-Muñoz MA, Pérez-Maya AA, Sánchez-Domínguez CN, et al. Multiple HPV infections and viral load association in persistent cervical lesions in mexican women. Viruses. 2020;12(4):380.
   PubMed Web of Science ®Google Scholar
• De Brot L, Pellegrini B, Moretti ST, et al. Infections with multiple high-risk HPV types are associated with high-grade and persistent low-grade intraepithelial lesions of the cervix. Cancer Cytopathol. 2017;125(2):138–143.
   PubMed Web of Science ®Google Scholar